Summary Information:
Orgenesis Inc. Common Stock
NASDAQ:ORGS


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Orgenesis Inc. Common Stock
Exchange: NASDAQ
Symbol: ORGS
SEC CIK: 0001460602
Phone: (480) 659-6404
20271 GOLDENROD LANE
GERMANTOWN MD 20876

CEO: Vered Caplan
Price when page updated: 0.4711 Date: 2023-12-01
Company Website:
www.orgenesis.com

_Description: Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensedPOCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies.

IPO YEAR:

Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
15017284.00
Beta:
1.459601318891553
52 Week High:
8.3
52 Week Low:
2.8
52 Week Change:
-0.39112050739957727
Short Interest:

Short Date:

Shares Outstanding:
24275276
Dividend Rate:
0
Dividend Yield:
1.33%
ExDividend Date:

Latest EPS:

Latest EPS Date:
26 Oct 2022
Float:
0
return on Equity:
-11.00%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$120.130M
ttmEPS:
0
Revenue:
$284.916M
Gross Profit:

Cash:

Debt:

Institution Percent:
58.10%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
15.70%
Return on Assets:
-3.50%
Return on Capital:

Profit Margin:
-2.60%
Price to Sales:
0.23
Price To Book:
0.98
Short Ratio:
4.15
PE Ratio:
0
Employees:
111
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Orgenesis Inc. Common Stock [ ORGS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01